Elizabeth Schmitz
Program: Immunology
Current advisor: Megan A. Cooper, MD, PhD
Undergraduate university: University of Pittsburgh, 2020
Enrollment year: 2022
Research summary
Using computational and cell biology techniques to study mosaicism as a genetic mechanism for errors of immunity.
I͛’m interested in using single-cell technology and cell biology approaches to understand the impact of somatic variants on immune dysregulation. I am interested in understanding how somatic variants influence the function of the immune system. I study patients that do not appear to have any germline cause of immune dysregulation to see if they have somatic variants that create similar clinical phenotypes or completely different clinical phenotypes compared to germline disease. The goal of my research is to diagnose patients with immune dysregulation more precisely to allow for more targeted treatment approaches.
Graduate publications
Schmitz E, Paul A, et al. 2026 Targeted Deep Sequencing Identifies Mosaicism in Patients with Immune Dysregulation. , ():
Schmitz EG, Paul AJ, Ghosh R, Saucier N, Kolicheski A, Risma SI, McDaniels KP, Liu M, Lewis KL, de Jesus AA, Alehashemi S, Fronick CC, Stein D, Dominguez D, Hiraki LT, Lee JH, Norman S, Peng CR, Ward BR, Pettiford LH, Platt A, Lawrence MG, Rocco JM, Al-Herz W, Zerbe CS, Atkinson TP, Peng XP, Allenspach EJ, Hoytema van Konijnenburg DP, Platt CD, Elkins M, Walter JE, Bleesing JJ, Klion A, Ramaswami R, Uzel G, Lionakis MS, Dissanayake D, Su HC, Cortese I, Fuss IJ, Bergerson JRE, Dropulic L, Sereti I, Lisco A, Itan Y, Milner JD, Bogunovic D, Goldbach-Mansky R, Rao VK, Delmonte OM, Notarangelo LD, Keller MD, Durkee-Shock J, Cohen JI, Similuk MN, Holland SM, Griffith M, Griffith OL, Vogel TP, Canna S, Freeman AF, Walkiewicz MA, Cooper MA. 2026 Targeted deep sequencing identifies mosaicism in patients with immune dysregulation. J Allergy Clin Immunol, 157(5):1179-1194. PMCID: PMC12916128
Ghosh R, Fazal Z, Oler AJ, Tokita MJ, Lewis KL, Paul AJ, Schmitz EG, Saucier N, Yan J, Kamen M, Seifert BA; NIAID Centralized Sequencing Program,; Klion AD, Khoury P, Delmonte OM, Notarangelo LD, Freeman AF, Zerbe CS, Uzel G, Metcalfe DD, Komarow HD, Carter MC, McDermott DH, Murphy PM, Olivier KN, Fuss I, Strober W, Rao VK, Bergerson JRE, Almeida de Jesus A, Goldbach-Mansky R, Al-Herz W, Holland SM, Cooper MA, Similuk MN, Walkiewicz MA. 2026 Clinical relevance of mosaic variants detected by exome sequencing.. J Allergy Clin Immunol, 157(5):1195-1205. PMCID: PMC13087911
Patel JA, Saucier N, Gil HM, Schmitz EG, Ruzinova MB, Saffaf A, Blinder M, Mehta-Shah N, Crees ZD, Cooper MA, Zimmerman O. 2026 Mosaic TLR8 gain-of-function in an elderly female treated with JAK inhibitor and adjunctive therapy. J Hum Immun, 2(6):e20260113. PMCID: PMC13603065
Arnold DE, Kaviany S, Aluri J, Calvo KR, Mehta SS, Tobin JM, Schuettpelz L, Saucier N, Schmitz EG, Murguía-Favela L, Wright NAM, De Ravin SS, Rao VK, Holland SM, Bleesing J, Loughran TP, Feith DJ, Powell J, Ratan A, Warren JT, Pai SY, Bednarski JJ, Connelly JA, Cooper MA. 2025 Clinical Characteristics, Management, and Hematopoietic Cell Transplantation of Patients with TLR8 Gain-of-Function. Blood Adv, 10(6):1967-1976. PMCID: PMC12997320
Schmitz E, Paul A, et al.. 2025 Deep Sequencing Reveals Somatic Mosaicism in Genes Relevant to Genetic Errors of Immunity in a Cohort of Patients with Immune Dysregulation. , ():